GJA1 and osteoporosis: A 3D bicellular endo‐osteo microfluidic platform is developed to explore pathogenic mechanisms underlying GCs‐induced osteoporosis, highlighting a novel MAPK/Connexin43 (Cx43) pathway that regulates bone microvascular barrier function and osteoblast‐endothelial interactions.